Education
About Us
Working with TipRanks
Follow Us
China Tian Yuan Healthcare Group Limited (HK:0557)
:0557
0557 Stock Chart & Stats
HK$0.70
-HK$0.10(-14.71%)
At close: 4:00 PM EST
HK$0.70
-HK$0.10(-14.71%)
Day’s Range― - ―
52-Week RangeHK$0.10 - HK$1.00
Previous CloseN/A
Volume26.00K
Average Volume (3M)3.33K
Market Cap
HK$279.29M
Enterprise ValueHK$293.62M
Total Cash (Recent Filing)HK$28.29M
Total Debt (Recent Filing)HK$40.80M
Price to Earnings (P/E)―
Beta-0.88
Next Earnings
Mar 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding398,979,520
10 Day Avg. Volume1,000
30 Day Avg. Volume3,326
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)1.07
Price to Sales (P/S)7.73
P/FCF Ratio19.44
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Diversified Business ModelChina Tian Yuan’s mix of traditional Chinese medicine, Western pharmaceuticals and healthcare services, plus partnerships with hospitals and clinics, creates diversified revenue streams and distribution channels. This reduces single-product dependence, supporting resilience and cross-selling opportunities over months.
Conservative LeverageA relatively low debt-to-equity position gives the company financial flexibility and lower fixed interest burdens. This conservative leverage supports the ability to fund operations or investments and absorb short-term shocks without immediate refinancing pressure, helping preserve strategic optionality.
Improving Cash GenerationReported positive operating cash flow and noted improvement in free cash flow indicate core operations can generate cash despite accounting losses. Durable cash generation supports working capital, selective capex or R&D funding and reduces near-term dependence on external financing if the trend continues.
Bears Say
Sharp Revenue DeclineA roughly 44% year-over-year revenue decline signals material loss of scale or demand and weakens market position. Sustained top-line contraction compresses operating leverage, reduces ability to absorb fixed costs, and undermines capacity to invest in product development or distribution over the medium term.
Persistent Profitability IssuesConsistent negative EBIT and net income reflect structural profitability problems rather than one-off items. Ongoing losses erode retained earnings, limit reinvestment, may force recurring cost containment or capital raises, and constrain management’s ability to execute strategic growth plans sustainably.
Eroding Shareholders' EquityA notable decline in shareholders’ equity from sustained losses weakens the capital buffer and financial resilience. Reduced equity lowers borrowing capacity, increases vulnerability to adverse shocks, and can restrict strategic options such as M&A or larger R&D investments until profitability and equity are rebuilt.
China Tian Yuan Healthcare Group Limited News
0557 FAQ
What was China Tian Yuan Healthcare Group Limited’s price range in the past 12 months?
China Tian Yuan Healthcare Group Limited lowest stock price was HK$0.10 and its highest was HK$1.00 in the past 12 months.
What is China Tian Yuan Healthcare Group Limited’s market cap?
China Tian Yuan Healthcare Group Limited’s market cap is HK$279.29M.
When is China Tian Yuan Healthcare Group Limited’s upcoming earnings report date?
China Tian Yuan Healthcare Group Limited’s upcoming earnings report date is Mar 26, 2026 which is in 30 days.
How were China Tian Yuan Healthcare Group Limited’s earnings last quarter?
China Tian Yuan Healthcare Group Limited released its earnings results on Aug 29, 2025. The company reported -HK$0.008 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.008.
Is China Tian Yuan Healthcare Group Limited overvalued?
According to Wall Street analysts China Tian Yuan Healthcare Group Limited’s price is currently Overvalued.
Does China Tian Yuan Healthcare Group Limited pay dividends?
China Tian Yuan Healthcare Group Limited does not currently pay dividends.
What is China Tian Yuan Healthcare Group Limited’s EPS estimate?
China Tian Yuan Healthcare Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Tian Yuan Healthcare Group Limited have?
China Tian Yuan Healthcare Group Limited has 398,979,520 shares outstanding.
What happened to China Tian Yuan Healthcare Group Limited’s price movement after its last earnings report?
China Tian Yuan Healthcare Group Limited reported an EPS of -HK$0.008 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 21.918%.
Which hedge fund is a major shareholder of China Tian Yuan Healthcare Group Limited?
Currently, no hedge funds are holding shares in HK:0557
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
China Tian Yuan Healthcare Group Limited
China Tian Yuan Healthcare Group Limited, an investment holding company, provides healthcare related services in Hong Kong, Korea, and the People's Republic of China. It operates through Investment Holding, Healthcare, Money Lending and Related Business, and Hospitality segments. The company offers procurement, marketing, and management services to the medical industry; and plastic surgery services, as well as licenses trademarks. It also invests in equity investments and marketable equitable equity mutual funds; offers loans and related services; introduces lenders and borrowers; and provides procurement services to hospitality industry. The company was formerly known as City e-Solutions Limited and changed its name to China Tian Yuan Healthcare Group Limited in November 2017. The company was incorporated in 1990 and is based in Wan Chai, Hong Kong. China Tian Yuan Healthcare Group Limited is a subsidiary of Tian Yuan Manganese Limited.
Technical Analysis
Shun Ho Property Investments Ltd
―
Century City International Holdings Limited
―
Paliburg Holdings Limited
―
Regal Hotels International Holdings Limited
―
ITC Properties Group Limited
―